000 | 01972 a2200613 4500 | ||
---|---|---|---|
005 | 20250517074632.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdw016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrucci, P F | |
245 | 0 | 0 |
_aBaseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2016 |
||
300 |
_a732-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIpilimumab |
650 | 0 | 4 | _aItaly |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 |
_aLymphocytes _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutrophils _xpathology |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aAscierto, P A | |
700 | 1 | _aPigozzo, J | |
700 | 1 | _aDel Vecchio, M | |
700 | 1 | _aMaio, M | |
700 | 1 | _aAntonini Cappellini, G C | |
700 | 1 | _aGuidoboni, M | |
700 | 1 | _aQueirolo, P | |
700 | 1 | _aSavoia, P | |
700 | 1 | _aMandalĂ , M | |
700 | 1 | _aSimeone, E | |
700 | 1 | _aValpione, S | |
700 | 1 | _aAltomonte, M | |
700 | 1 | _aSpagnolo, F | |
700 | 1 | _aCocorocchio, E | |
700 | 1 | _aGandini, S | |
700 | 1 | _aGiannarelli, D | |
700 | 1 | _aMartinoli, C | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 27 _gno. 4 _gp. 732-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdw016 _zAvailable from publisher's website |
999 |
_c25661628 _d25661628 |